Gunjan Verma - India

“This Guidance provides manufacturers of non-notified medical devices with the registration requirements applicable until October 1, 2022 for Class A and B devices and October 1, 2023 for Class C and D.”

Gunjan Verma
Managing Partner
Asia Actual India

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

India to Require All Medical Devices be Registered Before Importation

Published on: September 23rd, 2021

Medical Devices Will Now Need to Register Under One of Two Routes

On September 21, 2021, the CDSCO released the Guidance Document for Registration of Non Notified Medical Devices to provide additional clarity as the Voluntary registration deadline approaches on September 30, 2021. This Guidance provides manufacturers of non-notified medical devices with the registration requirements applicable until October 1, 2022 for Class A and B devices and October 1, 2023 for Class C and D.

Registration Requirements for Non-Notified Medical Devices

The new registration process for non-notified devices is the same process available under the previous voluntary registration process. The registration process is quick and only requires the manufacturer or their license holder to submit through an online portal which will provide a registration number upon completion. Once the registration number has been received, the manufacturer will need to update their labeling and adhere to post-market surveillance requirements.

Product information needed for the non-notified medical device registration:

  • Name of the company or firm or any other entity importing the medical device
  • Details of medical such as the generic name, intended use, classification, material, shelf life, etc.
  • Specification and standards of that medical device, ISO 13485 certificate
  • Free sale certificate from country of origin
  • Declaration of Conformity

Notified vs. Non-Notified Medical Devices

India’s CDSCO has been transitioning from The Drugs and Cosmetics Act of 1940 which only required 23 product categories of medical devices obtain approval before marketing. These competent authority-specified products are often referred to as Notified medical devices in the region. Effective April 1, 2020, the CDSCO began expanding the list of Notified products with October 1, 2021 being the first day all medical devices will need to be registered before importation.

Notified devices required a Device Master File (DMF) for each product depending on the intended use, brand name and other factors that can affect Grouping eligibility. Manufacturers of Notified Devices will also need to submit a Plant Master File (PMF) for each manufacturing site. Each manufacturing site will be designated an Import License number with all products manufactured at the site listed under it. For example, new products manufactured at 2 sites will require 2 PMFs and 2 DMFs. As all products become Notified in the next 2 years, it will be important for manufacturers to submit their DMFs and PMFs before the implementation deadlines to ensure market access isn’t lost.

Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia and with experienced, bi-lingual commercial and regulatory experts on the ground in each market. Contact Asia Actual today with any questions or support requests in India.

Blog Posts

CDSCO Issues Updates to IVD Classification List in India

The Central Drugs Standard Control Organisation (CDSCO) of India issued a notice (PDF) on October 25, 2023 classifying in-vitro diagnostic (IVD) medical devices under medical device rules. The updates to IVD classification in India include intended use, associated risk, and other parameters.

Embracing Innovation and Collaboration: Highlights from the 15th CII Global MedTech Summit

On October 6, 2023, a team of enthusiastic members from the AAI (Artificial Intelligence and Innovation) group, including Ashoniya Puri, Sanjay Singh, and Rajat Budhori, had the honor of attending the prestigious 15th CII Global MedTech Summit. Hosted by the Confederation of Indian Industry (CII), one of India's largest industry bodies, this event brought together key players in the MedTech sector, both from India and abroad. The summit revolved around the central theme, "Paving the way for a USD 50 billion MedTech Industry by 2030," signifying a collective vision for the industry's future growth.


On September 18, 2023, The Directorate General of Drug Administration (DGDA) published the Drug and Cosmetics Act 2023 formalizing the regulatory requirements of medical and diagnostic devices in Bangladesh with immediate effect.  A translated version of the document is available on Asia Actual’s website here.  All medical devices now require a Marketing Authorization Certificate to clear Customs and be sold on the market in Bangladesh.